Published date: Feb 07 2022

Journal Title: KnE Life Sciences

Issue title: 5th International Conference in Nursing (IVCN)

Pages: 664–676

DOI: 10.18502/kls.v7i2.10367

Windu Santosowindusantoso36@gmail.comDepartment of Nursing, Sekolah Tinggi Ilmu Kesehatan Bina Sehat PPNI Mojokerto, Indonesia

Sri SudarsihDepartment of Nursing, Sekolah Tinggi Ilmu Kesehatan Bina Sehat PPNI Mojokerto, Indonesia

Hypertension is one of the most common health conditions and comorbidities, and is considered a silent killer. One of the non-pharmacological efforts to help hypertensive patients control their blood pressure is through changes in lifestyle to become healthier, and it is the role of nurses to promote these changes. This study aimed to determine the impact of the Healthy Lifestyle Change Plan (RPGHS) card on healthy lifestyle behaviors of hypertension sufferers. This research was a pre-experimental study with a one-group pretest-posttest design. The sample consisted of 36 patients recruited through purposive sampling. The data were collected using an observation sheet (RPGHS card) which was used to identify the lifestyle of people with hypertension; lifestyle behaviors measured included maintaining an ideal body weight, salt consumption, stress management, smoking habits, physical activity, and checking blood pressure. Assistance was carried out for two days. Data were analyzed using the Kolmogorov Smirnov test and paired t-test, which showed that there was a significant difference in healthy lifestyle behaviors before and after the mentoring (p < 0.001). The RPGHS card made it easy for patients to plan healthier lifestyle changes to implement in daily life. So, this is recommended as an instrument to help hypertensive patients in the process of behavior change.

Keywords: hypertension, healthy lifestyle, change, RPGHS Card

[1] Burhan E. Pedoman tatalaksana Covid-19. 3rd ed. Perhimpunan Dokter Paru Indonesia (PDPI), Perhimpunan Dokter Spesialis Kardiovaskular Indonesia (PERKI), Perhimpunan Dokter Spesialis Penyakit Dalam Indonesia (PAPDI), Perhimpunan Dokter Anestesiologi dan Terap; 2020.

[2] Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. The New England Journal of Medicine. 2020;382:727–733.

[3] Pane, P. Penyakit virus corona 19 (Covid-19). 2020.

[4] Firdaus. Panduan diagnosis dan tatalaksana penyakit kardiovaskuler pada pandemi covid -19. 2020.

[5] Rokom. 132. Available from: persen-pasien-covid-19-meninggal-memiliki-penyakithipertensi

[6] Sardu C, Gambardella J, Morelli MB, et al. Hypertension, thrombosis, kidney failure, and diabetes: Is Covid-19 an endothelial disease? A comprehensive evaluation of clinical and basic evidence. Journal of Clinical Medicine. 2020;9:1417.

[7] Guan. Comorbidity and its impact on 1590 patients with COVID-19 in China: A nationwide analysis. Pneumologie. 2020;74:640.

[8] Yang J, Zheng Y, Gou X, et al. Prevalence of comorbidities and its effects in coronavirus disease 2019 patients: A systematic review and meta-analysis. International Journal of Infectious Diseases. 2020;94:91–95.

[9] Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-infected pneumonia in Wuhan, China. JAMA The Journal of the American Medical Association2020;323:1061–1069.

[10] Kemenkes RI. Available from: 13-2-persen-pasien-covid-19-yang-meninggalmemiliki- penyakit-hipertensi.

[11] Karyono DR, Wicaksana AL. Current prevalence, characteristics, and comorbidities of patients with COVID-19 in Indonesia. Journal of Community Empowerment for Health. 2020;3:77.

[12] Kulkarni. COVID-19 and hypertension. JRAAS - J Renin-Angiotensin-Aldosterone Syst. 2020;21. DOI: 10.1177/1470320320927851

[13] Ahmadi S, Sa H, Ah N, et al. Lifestyle modification strategies for controlling hypertension: How are these strategies recommended by physicians in Ir.

[14] Stanulewicz N, Knox E, Narayanasamy M, et al. Effectiveness of lifestyle health promotion interventions for nurses: A systematic review. International Journal of Environmental Research and Public Health. 2020;17. DOI: 10.3390/ijerph17010017

[15] Jones S. A comparison of hypertension management perceptions, knowledge and stage of change among hospital employees. Diss Abstr Int Sect A Humanit Soc Scri. 77.

[16] Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. 2014;16. DOI: 10.1111/jch.12237

[17] Siervo M, Lara J, Chowdhury S, et al. Effects of the dietary approach to stop hypertension (DASH) diet on cardiovascular risk factors: A systematic review and meta-analysis. British Journal of Nutrition. 2015;113:1–15.

[18] Mungal-Singh V. Lifestyle changes for hypertension. South African Family Practice2012;54:37–41.

[19] Schwartz GL, Sheps SG. A review of the sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Current Opinion in Cardiology2004;14:161–168.

[20] Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC guidelines for the management of arterial hypertension: The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal. 2013;34:2159–2219.

[21] Topcuoglu H, Yanik A. Assessment of extent of lifestyle modification among diagnosed patients of hypertension attending tertiary care hospital. International Journal of Occupational and Environmental Health. 2014;2:301–307.

[22] Maiyaki M, Garbati M. The burden of non-communicable diseases in Nigeria; In the context of globalization. Ann Afr Med 2014;13:1–10.

[23] Cosimo Marcello B, Maria Domenica A, Gabriele P. Lifestyle and hypertension: An evidence-based review. Journal of Hypertension and Management. 2018;4:1–10.

[24] Buda ES, Hanfore LK, Fite RO, et al. Lifestyle modification practice and associated factors among diagnosed hypertensive patients in selected hospitals, South Ethiopia. Clinical Hypertension. 2017;23:1–9.

[25] Beevers DG, Gregory YH, Lip ETO. ABC of hypertension. 6th ed. 2014.

[26] Beck DT, Martin JS, Casey DP. Exercise training reduces peripheral arterial stiffness and myocardial oxygen demand in young prehypertensive subjects. American Journal of Hypertension. 2013;26:1093–1102.

[27] Nyberg M, Mortensen SP, Hellsten Y. Physical activity opposes the age-related increase in skeletal muscle and plasma endothelin-1 levels and normalizes plasma endothelin-1 levels in individuals with essential hypertension. Acta Physiologica. 2013;207:524–535.

[28] World Health Organization. Noncommunicable diseases (NCD).

[29] Lange KW, Nakamura Y. Movement and nutrition in COVID-19. 89 movement and nutrition in health and disease. Movement-NutritionDe. 2020;4:89–94.

[30] Wypych TP, Marsland BJ, Ubags NDJ. The impact of diet on immunity and respiratory diseases. Annals of the American Thoracic Society. 2017;14:S339–S347.

[31] Chen P, Mao L, Nassis GP, et al. Coronavirus disease (COVID-19): The need to maintain regular physical activity while taking precautions. Journal of Sport and Health Science2020;9:103–104.

[32] Constandt B, Thibaut E, De Bosscher V, et al. Exercising in times of lockdown: An analysis. Constandt B, Thibaut E, De Bosscher V, Scheerder J, Ricour M, Willem A. Exercising in times of lockdown: An analysis of the impact of COVID-19 on levels and patterns of exercise among adults i. International Journal of Environmental Research and Public Health. 2020;17:1–10.

[33] Hall G, Laddu DR, Phillips SA. A tale of two pandemics: How will COVID-19 and global trends in physical inactivity and sedentary behavior affect one another? 2020. DOI: doi.org/10.1016/j.pcad.2020.04.005

[34] Burton R, Sheron N. No level of alcohol consumption improves health. Lancet. 2018;392:987–988.

[35] Imtiaz S, Shield KD, Roerecke M, et al. Alcohol consumption as a risk factor for tuberculosis: Meta-analyses and burden of disease. European Respiratory Journal. 2017;50. DOI: 10.1183/13993003.00216-2017

[36] Lippi G, Henry BM. Active smoking is not associated with severity of coronavirus disease 2019 (COVID-19). European Journal of Internal Medicine. 2020;75:107–108.

[37] Guan W, Ni Z, Hu Y, et al. Clinical characteristics of coronavirus disease 2019 in China. The New England Journal of Medicine. 2020; 382:1708–1720.

[38] Zhang J, Dong X, Cao Y, et al. Clinical characteristics of 140 patients infected with SARS-CoV-2 in Wuhan, China. Allergy Eur J Allergy Clin Immunol. 2020;75:1730– 1741.

[39] Dennis S, Williams A, Taggart J, et al. Which providers can bridge the health literacy gap in lifestyle risk factor modification education: A systematic review and narrative synthesis. BMC Fam Practice. 2012;13. DOI: 10.1186/1471-2296-13-44

[40] Tam HL, Mi E, Wong L, et al. Effectiveness of educational interventions on adherence to lifestyle modifications among hypertensive patients: An integrative review.

[41] Akbarpour S, Khalili D, Zeraati H. Healthy lifestyle behaviors and control of hypertension among adult hypertensive patients. 2018:1–9.

[42] Angelo AT, Geltore TE, Sciences H, et al. Lifestyle modification practice and associated factors among diagnosed hypertensive patients in Mizan Tepi University Teaching Hospital South west Ethiopia, 2019: Cross-sectional study. 2020;2797:1–12.

[43] Lin CH, Chiang SL, Tzeng WC, et al. Systematic review of impact of lifestyle modification programs on metabolic risks and patient-reported outcomes in adults with metabolic syndrome. Worldviews Evidence-Based Nurse. 2014;11:361–368.

[44] Yamaoka K, Tango T. Effects of lifestyle modification on metabolic syndrome: A systematic review and meta-analysis. BMC Medicine. 2012;10. DOI: 10.1186/1741-7015- 10-138

[45] Akinlua JT, Meakin R, Umar AM, et al. Current prevalence pattern of hypertension in Nigeria: A systematic review. PLoS One. 2015;10:1–18.

[46] Adeloye D, Basquill C, Obi FA. An estimate of the prevalence of hypertension in Nigeria: A systematic review and meta-analysis. Journal of Hypertension. 2015;33:230–242.

[47] Bauer UE, Briss PA, Goodman RA, et al. The health of Americans. Prevention of chronic disease in the 21st century: Elimination of the leading preventable causes of premature death and disability in the USA. Lancet. 2014;384:45–52.

[48] World Health Organization. Noncommunicable disease progress monitor 2017. Geneva: WHO; 2017.

[49] Crittenden D, Seibenhener S, Hamilton B. Health coaching and the management of hypertension. TJNP J Nurse Pract. 2017:1–3.

[50] Finer N, Garnett SP, Bruun JM. COVID-19 and obesity. Clinical Obesity. 2020;10:1–2.

[51] Lighter J, MD MP, MD SH. Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission. Cancer. 2020;46:1–17.

[52] Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study. Lancet. 2020;395:1054–1062.

[53] Chu DK, Akl EA, Duda S, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: A systematic review and meta-analysis. Lancet. 2020;395:1973–1987.